NEW YORK (GenomeWeb News) – Gene expression company Genometry has raised $3 million in a Series A equity round of funding.

Genometry President and CEO Justin Lamb said that the funds will go toward establishing its operations and running the business. According to the company's Form D filed with the US Securities and Exchange Commission, the round had 11 investors. Lamb declined to identify the investors in the round but said they comprise venture firms, private equity firms, and a corporate strategic investor.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.